Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT02655822
Brief Title: Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

First Submitted : January 8, 2016
First Submitted that Met QC Criteria : January 13, 2016
First Posted : January 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 27, 2021
Last Update Posted : August 30, 2021